Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of 110 mg ketoprofen
in Transfersome applied to the skin twice daily as compared to placebo and oral celecoxib 200
mg per day for the relief of signs and symptoms of osteoarthritis of the knee for a period of
six weeks.